Advertisement

Endoscopic Treatment of Early Esophageal Cancer

  • Roos E. PouwEmail author
  • Bas L. A. M. Weusten
Chapter

Abstract

Esophageal cancer limited to the mucosa and low-risk submucosal adenocarcinoma, are associated with a low risk of lymph node and distant metastasis. For these early esophageal cancers, endoscopic treatment has evolved as a minimally invasive and organ preserving alternative to surgery. Endoscopic resection (ER) is the cornerstone of endoscopic therapy. ER not only removes neoplastic lesions, it also provides a substantial tissue specimen enabling accurate histological staging. Histological assessment of infiltration depth, grade of differentiation and presence of lymphovascular invasion are crucial in selecting patients who are eligible for further endoscopic management.

In patients with early adenocarcinoma arising in Barrett’s esophagus, a number of techniques are available to eradicate all Barrett’s mucosa after focal removal of early neoplastic lesions. Removal of all residual Barrett’s mucosa is advised to minimize the risk of metachronous lesions during follow-up.

In this book chapter we will give an overview of the indications for endoscopic treatment, different techniques that are available for endoscopic resection, management of the patient after focal removal of early cancer, and future perspectives on the place of endoscopic treatment for early esophageal cancer.

Keywords

Esophagus Cancer Early Endoscopic treatment 

Supplementary material

Video 3.1

EMR (MP4 218688 kb)

References

  1. 1.
    Pech O, May A, Manner H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146:652–60.CrossRefPubMedGoogle Scholar
  2. 2.
    Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70:860–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Inoue H, Endo M, Takeshita K, et al. A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg Endosc. 1992;6:264–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Peters FP, Kara MA, Rosmolen WD, et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc. 2005;61:506–14.CrossRefPubMedGoogle Scholar
  5. 5.
    Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.CrossRefPubMedGoogle Scholar
  6. 6.
    Phoa KN, Pouw RE, van Vilsteren FG, et al. Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology. 2013;145:96–104.CrossRefPubMedGoogle Scholar
  7. 7.
    Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRefPubMedGoogle Scholar
  8. 8.
    Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446:497–504.CrossRefPubMedGoogle Scholar
  9. 9.
    Alvarez Herrero L, Pouw RE, van Vilsteren FG, et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy. 2010;42:1030–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Manner H, Pech O, Heldmann Y, et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29:1888–96.CrossRefPubMedGoogle Scholar
  11. 11.
    Boys JA, Worrell SG, Chandrasoma P, et al. Can the risk of lymph node metastases be gauged in endoscopically resected submucosal esophageal adenocarcinomas? A multi-center study. J Gastrointest Surg. 2016;20:6–12.CrossRefPubMedGoogle Scholar
  12. 12.
    Schölvinck DW, Künzli HT, Meijer SL, et al. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc. 2016;30:4102–13.CrossRefPubMedGoogle Scholar
  13. 13.
    Manner H, Wetzka J, May A, et al. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2–3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns. Dis Esophagus. 2016 [Epub ahead of print].Google Scholar
  14. 14.
    The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58:S3–43.Google Scholar
  15. 15.
    Peters FP, Brakenhoff KP, Curvers WL, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc. 2008;67:604–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Araki K, Ohno S, Egashira A, et al. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Yoshii T, Ohkawa S, Tamai S, Kameda Y. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer. Dis Esophagus. 2013;26:496–502.CrossRefPubMedGoogle Scholar
  18. 18.
    Van Vilsteren FG, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut. 2011;60:765–73.CrossRefPubMedGoogle Scholar
  19. 19.
    He S, Bergman J, Zhang Y, et al. Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial. Endoscopy. 2015;47:398–408.CrossRefPubMedGoogle Scholar
  20. 20.
    Pouw RE, van Vilsteren FG, Peters FP, et al. Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc. 2011;74:35–43.CrossRefPubMedGoogle Scholar
  21. 21.
    Alvarez Herrero L, Pouw RE, van Vilsteren FG, et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy. 2011;43:177–83.CrossRefPubMedGoogle Scholar
  22. 22.
    Terheggen G, Horn EM, Vieth M, et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett’s neoplasia. Gut. 2016 [Epub ahead of print].Google Scholar
  23. 23.
    Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–5.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Manner H, May A, Kouti I, et al. Efficacy and safety of hybrid-APC for the ablation of Barrett’s esophagus. Surg Endosc. 2016;30:1364–70.CrossRefPubMedGoogle Scholar
  25. 25.
    Schölvinck DW, Künzli HT, Kestens C, et al. Treatment of Barrett’s esophagus with a novel focal cryoablation device: a safety and feasibility study. Endoscopy. 2015;47:1106–12.CrossRefPubMedGoogle Scholar
  26. 26.
    Rosmolen WD, Nieuwkerk PT, Pouw RE, et al. Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett’s neoplasia: a prospective study. Dis Esophagus. 2016 [Epub ahead of print].Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Gastroenterology and HepatologyAcademic Medical CenterAmsterdamThe Netherlands
  2. 2.Department of Gastroenterology and HepatologySt. Antonius HospitalNieuwegeinThe Netherlands

Personalised recommendations